Kilimanjaro Christian Medical Centre
Moshi, Tanzania
NCT Number: NCT02888288
The purpose of this study is to evaluate if a group-based mental health intervention called Sauti ya Vijana (The Voice of Youth) designed to address mental health challenges faced by adolescents in Tanzania is acceptable and feasible and if it improves mental health, antiretroviral therapy (ART) adherence, and virologic outcomes among HIV-positive adolescents as compared to youth receiving treatment as usual. Mental health intervention sessions will take place three times a month for approximately four months in groups of eight to ten youth based on age and sex. Caregivers will attend two sessions to support the youth and provide the guardian perspective on caring for HIV-positive adolescents. The investigator hypothesizes the mental health intervention will be acceptable, feasible, and will improve mental health and ART adherence among participating youth and this improvement will be sustained over time.
Looking for future studies?
Notify Me12 year–24 year
All sexes
Interventional
Not applicable
Moshi, Tanzania
The study will enroll up to approximately 130 participants from the established Kilimanjaro Christian Medical Centre and Mawenzi Saturday Teen Clinics. Participants will be assigned to approximately eight to ten persons per group, based on age and sex. Groups will be matched in pairs as closely as possible (ex. two groups of females 12-16 years of age) and assigned to Wave 1, 2, or 3. Randomization will occur on the individual level and will occur just before the start of mental health intervention for each wave. Individuals will be randomized at this time point to reduce potential drop out of those with delayed start (Wave 2/3). Randomization will occur by a coin flip for two individuals based on alphabetical order: heads will be intervention group (I) and tails the standard of care group (SOC).
This feasibility study is longitudinal with up to 24 month follow-up after intervention. Feasibility measures from lay counselors will be monitored weekly. Outcome measures will be obtained by blinded interviewers using a structured survey to inquire about mental health symptoms, self-report adherence, obtain an ART drug concentration level from a hair sample, and HIV-1 viral load from a blood sample and will be collected by the same research assistants at five to six potential time points: 1) baseline, 2) pre-intervention, 3) post-intervention, 4) 6-months post-intervention, 5) 12-months post-intervention and 6) 24-months post-intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Includes a standard format of greetings, review of last session content, homework discussion, new topic, assigning homework and ends with a fun activity, relaxation or game. First session is a joint session with youth and caregivers. Topics include common stresses and worries experienced by HIV+ youth; relaxation and coping techniques; cognitive behavioral triangle; story of finding out HIV status and if willing, to discuss this in an individual session, peer group session, and with caregiver; identify circles of support; discuss stigma and how to disclose HIV status to others; consider values, hopes and dreams for the future, and how to use this information to live positively with HIV. ART adherence is woven into case examples and discussions.
Standard of Care includes enhanced ART adherence based on clinic protocols and monthly HIV teaching sessions prior to adolescent clinic.
Time frame: weekly for 16 weeks during each intervention wave (over 2 years)
Measure the percentage of participants who complete all intervention sessions and ability to interview participants for outcome measures over time.
Time frame: during 2 caregiver sessions
Record willingness of caregivers to participate (if unwilling, why not) and attendance.
Time frame: during 2 caregiver sessions
Time frame: weekly for 16 weeks during the intervention wave (over 2 years)
Time frame: weekly for 16 weeks during the intervention wave (over 2 years)
Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare the change in standard deviation of mental health symptoms on the PHQ-9, between the intervention group versus SOC.
Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare the change in standard deviation of mental health symptoms on the SDQ, between the intervention group versus SOC.
Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare the change in standard deviation of mental health symptoms on the UCLA PTSD-RI, between the intervention group versus SOC.
Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare the change in self-report adherence between the intervention group versus SOC.
Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Describe the proportion of youth with viral suppression (HIV-1 RNA < 400 copies/ml) in the intervention group and SOC.
Time frame: pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Compare self-report ART adherence with drug level concentration of hair samples.
Time frame: baseline to post-intervention, 6-, 12-,18- and 24-months
Compare the change in standard deviation of mental health symptoms on the PHQ-9, SDQ, UCLA PTSD-RI at the individual level.
Time frame: baseline to post-intervention, 6-, 12-, and 24-months
Compare the change in self-reported adherence and antiretroviral drug concentration in hair.
Time frame: baseline to post-intervention, 6-, 12-, and 24-months
Compare the change in HIV viral load.
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03885401
Behavior, Chronic Disease
Richmond, Virginia, United States
View Trial DetailsNCT05173675
Behavior, Diabetes
Austin, Texas, United States
View Trial DetailsNCT06822075
Behavior, Health Behavior
Lyon, France
View Trial DetailsNCT06592443
Behavior, Disease Attributes
Singapore
View Trial Details